Search results for “CYP3A4” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 331 patents, we discovered top 92 key players by total patent application. Bow River LLC, Neurocrine Biosciences, Inc., Pfizer Products, Inc. are dominant in this area. They take 25.38% of the total patent filing.
Bow River LLC
United States
Patent: 38
Neurocrine Biosciences, Inc.
California, United States
Patent: 31
Pfizer Products, Inc.
Connecticut, United States
Patent: 15
Abbott Laboratories
Illinois, United States
Patent: 13
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 13
Corcept Therapeutics, Inc.
California, United States
Patent: 9
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 9
Veloxis Pharmaceuticals, Inc.
New Jersey, United States
Patent: 9
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 8
Syndax Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 8
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 147 patents applied in the last 5 years. We discover 50 most active companies in this area. The fast-growing Bow River LLC, Neurocrine Biosciences, Inc., Corcept Therapeutics, Inc. take 36.05% of patent filing during this period.
Bow River LLC
United States
Patent: 31
Neurocrine Biosciences, Inc.
California, United States
Patent: 13
Corcept Therapeutics, Inc.
California, United States
Patent: 9
Syndax Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 8
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 6
FUJIFILM Corp.
Tokyo-to, Japan
Patent: 4
Horizon Therapeutics LLC
Nevada, United States
Patent: 3
Shanghai Enyuan Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 3
The Johns Hopkins University
United States
Patent: 3
Immedica Pharma AB
Sweden
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 147 patents in last 5 years, we discover 43 new entrants. Corcept Therapeutics, Inc., Syndax Pharmaceuticals, Inc., FUJIFILM Corp. are the most active new entrants in this area.
Corcept Therapeutics, Inc.
California, United States
Patent: 9
Syndax Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 8
FUJIFILM Corp.
Tokyo-to, Japan
Patent: 4
The Johns Hopkins University
United States
Patent: 3
Shanghai Enyuan Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 3
Immedica Pharma AB
Sweden
Patent: 3
The First Affiliated Hospital of Nanchang University
undefined undefined
Patent: 2
Xenon Pharmaceuticals, Inc.
British Columbia, Canada
Patent: 2
Global Blood Therapeutics, Inc.
California, United States
Patent: 2
Anhui Ronghang Biotechnology Development Co., Ltd.
Anhui Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 110 patents, we discovered top 34 universities and scientific research institutions by total patent application. The University of Sydney, Duke University, Zhejiang University are dominant in this area. They take 38.18% of the total patent filing.
The University of Sydney
Australia
Patent: 29
Duke University
North Carolina, United States
Patent: 4
Zhejiang University
Zhejiang Sheng, China
Patent: 4
The Children's Hospital of Philadelphia
Pennsylvania, United States
Patent: 4
The Johns Hopkins University
United States
Patent: 3
University of Saskatchewan
Saskatchewan, Canada
Patent: 3
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 3
Kyushu University
Fukuoka-ken, Japan
Patent: 2
Wenzhou Medical College
Zhejiang Sheng, China
Patent: 2
Shanghai Normal University
Shanghai Shi, China
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: